Six months’ treatment with MIV-711, a novel Cathepsin K inhibitor induces osteoarthritis structure modification: results from a randomized double-blind placebo-controlled phase IIA trial
Conaghan, P.G., Bowes, M.A., Kingsbury, S.R., Brett, A., Guillard, G., Tunblad, K., Rizoska, B., Larsson, T., Holmgren, Å., Manninen, A., Göhlin, K., Heber, W., Graham, P., Jansson, Å., Wadell, C., BeТом:
26
Мова:
english
Журнал:
Osteoarthritis and Cartilage
DOI:
10.1016/j.joca.2018.02.066
Date:
April, 2018
Файл:
PDF, 258 KB
english, 2018
File converter
Більше результатів пошуку
More benefits 
